Moderna Inc. has some of the highest-flying science in the biotech business. It brought its messenger RNA vaccine to the market in less than a year, faster than almost anyone…
The World Health Organisation on Wednesday said it expects to receive clarifications from Bharat Biotech by the end of this week on its COVID-19 vaccine — Covaxin — and will…
By Jeff Mason WASHINGTON – The African Union (AU) intends to buy up to 110 million doses of COVID-19 vaccine from Moderna Inc in an arrangement brokered in part by…
PUNE: Two Pune hospitals are among the 11 trial sites in India where adolescents are being screened for US pharma major Johnson & Johnson’s Covid vaccine advanced trials this month.…
Hyderabad-based Bharat Biotech, the manufacturer of indigenous Covid-19 vaccine Covaxin, is aiming to produce 70-80 million doses monthly from December, lagging way behind the government’s 400 million production estimate between…
PUNE: ZyCoV-D, the first vaccine to be approved for use in children above the age of 12 in India, will be also be made available to private sector hospitals across…
By Johan Ahlander STOCKHOLM: Scientists behind COVID-19 vaccines could be in the running to win the Nobel Prize for Medicine even though the pandemic is far from over. Some scientists…
New Delhi [India]: The discussion on the pricing of Zydus Cadila’s COVID-19 vaccine ZyCoV-D is underway, said Dr VK Paul, Member (Health) NITI Aayog on Tuesday. “The discussion on the…
New Delhi: Considering the burden on healthcare and the expense of buying three doses, Zydus Cadila is planning to seek approval for the two-dose regimen of its needle-free COVID-19 vaccine,…
Several hundred people line up every morning, starting before dawn, on a grassy area outside Nairobi’s largest hospital hoping to get the covid-19 vaccine. Sometimes the line moves smoothly, while…
